CHME (CHME) Stock Price & Analysis
CHME (CHME) rose 28.75% to USD 0.04 as of June 10, 2026 at 06:03 UTC, according to Nexqual real-time market data.
CHME last closed at USD 0.03; the session ranged USD 0.04–0.04 on volume of 131,501 shares. Market capitalization is $976,936, with a 52-week range of USD 0–0.04 (PNK). Source: Nexqual, June 10, 2026 at 06:03 UTC.
Key Statistics (as of June 10, 2026 at 06:03 UTC)
| Price | USD 0.04 |
|---|---|
| Change | ▲ 28.75% (up) |
| Previous Close | USD 0.03 |
| Open | USD 0.04 |
| Day Range | USD 0.04 – 0.04 |
| 52-Week Range | USD 0 – 0.04 |
| Volume | 131,501 shares |
| Market Cap | $976,936 |
| Exchange | PNK |
Technical Analysis (CHME)
Nexqual's technical model rates CHME "BUY" based on 5 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 06:03 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0.02) |
| MACD | 0 (positive) |
Analyst Ratings (CHME)
Wall Street analysts rate CHME "None", per Nexqual as of June 10, 2026 at 06:03 UTC.
| Consensus Rating | None |
|---|
Earnings (CHME)
Source: Nexqual, June 10, 2026 at 06:03 UTC.
Financials & Fundamentals (CHME)
| Total Revenue | $65.76M |
|---|---|
| Revenue Growth (YoY) | -8.40% |
| Gross Margin | +33.46% |
| Operating Margin | +14.16% |
| Profit Margin | +9.17% |
| ROE | +6.63% |
| Debt / Equity | 3.23 |
| Current Ratio | 11.15 |
| Total Cash | $7.85M |
| Total Debt | $4.05M |
| Free Cash Flow | $-44.62M |
Source: Nexqual, June 10, 2026 at 06:03 UTC.
Financial Health Score (CHME)
Nexqual rates CHME's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 06:03 UTC.
| Growth | Weak — Revenue -8% YoY (latest Q), declining |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 14% |
| Balance Sheet | Strong — $8M cash vs $4M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$45M, burning cash |
| Efficiency | Mixed — ROE 7%, ROA 7.8% |
Ownership (CHME)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 23.71M |
Source: Nexqual, June 10, 2026 at 06:03 UTC.
Leadership (CHME)
CHME is led by Senshan Yang (age 64), Chairman, CEO & Chairman of Guangzhou Konzern Medicine Co., Ltd, per Nexqual as of June 10, 2026 at 06:03 UTC.
| Chairman, CEO & Chairman of Guangzhou Konzern Medicine Co., Ltd | Senshan Yang (age 64) |
|---|---|
| Chief Financial Officer | Ho Chi Fung (age 53) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CCGY | China Clean Energy, Inc. | USD 0 | ▲ 0% |
| LTUS | Lotus Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| CSGH | CHINA SUN GROUP HIGH-TECH CO | USD 0 | ▲ 0% |
| CIWT | CHINA INDUSTRIAL WASTE MGMT INC | USD 0 | ▲ 0% |
| CHFI | CHINA FINANCE INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 06:03 UTC. This page is informational and not investment advice.